PeptidesCalculator.org Unveils Free Retatrutide Dosage Calculator to Streamline Research Protocols

New York, United States, Aug. 17, 2026 (GLOBE NEWSWIRE) — PeptidesCalculator.org, a leading provider of digital solutions for peptide research, today announced the launch of its new, free-to-use dedicated tool: the retatrutide dosage calculator. Engineered to deliver precision and eliminate manual mathematical errors, the web-based utility simplifies complex reconstitution and dosing math for researchers working with next-generation triple-agonist peptides.

CORRECTION: TDECU Board Elects Lavonne Burke as New Chair

Houston, TX, Aug. 17, 2026 (GLOBE NEWSWIRE) — TDECU has elected attorney and technology executive Lavonne Burke as Chair of its Board of Directors, signaling a continued focus on innovation, governance and long-term growth for the Houston region’s largest credit union. Burke, who joined the TDECU Board in 2023, is the first woman to serve as Board Chair in TDECU’s 71-year history.

Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors

BOTHELL, Wash., Aug. 17, 2026 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company developing novel therapeutics to meet the growing global need for effective, safe antiviral treatments, today announced the appointment of Carol Brosgart, MD to its Board of Directors, effective August 12, 2026. Dr. Brosgart brings several decades of experience in antiviral therapy, epidemiology, and biopharma advisory.

Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors

BOTHELL, Wash., Aug. 17, 2026 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company developing novel therapeutics to meet the growing global need for effective, safe antiviral treatments, today announced the appointment of Carol Brosgart, MD to its Board of Directors, effective August 12, 2026. Dr. Brosgart brings several decades of experience in antiviral therapy, epidemiology, and biopharma advisory.

In National Advertising Division Challenge, Quanovate Tech Voluntarily Discontinues Mira Fertility Monitor and Test Wand Claims

Following a BBB National Programs’ National Advertising Division challenge brought by The Procter & Gamble Company (P&G), Quanovate Tech, Inc. voluntarily discontinued claims for its Mira Fertility Monitor and Test Wands.

Following a BBB National Programs’ National Advertising Division challenge brought by The Procter & Gamble Company (P&G), Quanovate Tech, Inc. voluntarily discontinued claims for its Mira Fertility Monitor and Test Wands. 

OZOP Energy Solutions, Inc. Highlights Boardroom Feature on Ballislife HYDRO Investor Egypt Dean

WARWICK, NY, Aug. 17, 2026 (GLOBE NEWSWIRE) — OZOP Energy Solutions, Inc. (OTC: OZSC) today commented on new insights into the investment thesis behind Egypt Dean’s seven-figure strategic investment in Ballislife HYDRO Sports Drink, following an in-depth interview published by Boardroom. The feature explores how Dean evaluated the opportunity, the importance he placed on the product and management team, and the process that ultimately led him to invest in Ballislife Drink Inc., a joint venture between Varon Corp.’s U.S. subsidiary, Varon USA, and Ballislife, Inc. OZOP Energy Solutions, Inc. and Varon Corp. are currently completing customary pre-closing conditions in connection with the previously announced transaction.

OZOP Energy Solutions, Inc. Highlights Boardroom Feature on Ballislife HYDRO Investor Egypt Dean

WARWICK, NY, Aug. 17, 2026 (GLOBE NEWSWIRE) — OZOP Energy Solutions, Inc. (OTC: OZSC) today commented on new insights into the investment thesis behind Egypt Dean’s seven-figure strategic investment in Ballislife HYDRO Sports Drink, following an in-depth interview published by Boardroom. The feature explores how Dean evaluated the opportunity, the importance he placed on the product and management team, and the process that ultimately led him to invest in Ballislife Drink Inc., a joint venture between Varon Corp.’s U.S. subsidiary, Varon USA, and Ballislife, Inc. OZOP Energy Solutions, Inc. and Varon Corp. are currently completing customary pre-closing conditions in connection with the previously announced transaction.